Glucotrack, Inc. current report, 10 September 2026

Business Context and Reporting Period

Glucotrack, Inc. (GCTK), a Delaware corporation, filed this Form 8-K on September 10, 2026, to report the entry into a material definitive agreement. The filing details a private placement financing transaction closed on September 10, 2026, involving the issuance of senior secured convertible promissory notes and warrants to certain investors.

Key Financial Metrics and Transaction Details

  • Gross Proceeds: $4,500,000 in cash consideration.
  • Total Principal Amount of Notes: $11,596,172.68.
  • Debt Refinancing: $4,545,014.69 of existing senior secured convertible promissory notes were surrendered and exchanged for the new Notes.
  • Original Issue Discount (OID): 22% (reflecting a purchase price of $9,045,014.69 for the total principal).
  • Interest Rate: 8% per annum; increases to 18% per annum upon an Event of Default.
  • Maturity: Nine (9) months from September 10, 2026.
  • Collateral: Secured by a security interest in substantially all assets of the Company and its subsidiaries.
  • Warrants Issued: 4,831,739 shares at an exercise price of $7.50 per share, exercisable for five years.
  • Placement Agent Fees: 7% cash fee on gross proceeds plus warrants to purchase 148,668 shares.

Material Changes and Terms

The primary material change is the restructuring of debt and the injection of new capital. The transaction replaced approximately $4.55 million in existing debt with new notes carrying a higher aggregate principal due to the OID structure. The new Notes feature a conversion price equal to the lower of $3.12 (Nasdaq Minimum Price) or 80% of the lowest 15-day VWAP, subject to a floor price of 20% of the Nasdaq Minimum Price. An "Exchange Cap" limits the total shares issuable upon conversion and warrant exercise to 19.99% of the pre-transaction outstanding common stock unless stockholder approval is obtained.

Guidance, Risks, and Contingencies

  • Stockholder Approval Requirement: The Company must file a proxy statement within 30 days and obtain stockholder approval within 90 days to issue shares exceeding the 19.99% Exchange Cap. Failure to hold the meeting or obtain approval triggers the issuance of "Penalty Shares."
  • Registration Rights: The Company must file a registration statement within 10 days and have it declared effective within 45 days. Failure to meet these deadlines results in the issuance of Penalty Shares.
  • Most Favored Nation: Investors have the right to exchange their securities for terms of any subsequent financing if those terms are more favorable.
  • Lock-up Restrictions: The Company is restricted from issuing new equity or entering into variable rate transactions for 90 days following the effective date of the registration statement and stockholder approval.
  • Financial Impact: The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period, as this is a transactional filing rather than a periodic financial report.

Investor Verification Checklist

  • Verify the Company's ability to obtain stockholder approval within the 90-day window to avoid Penalty Shares and unlock the full conversion potential.
  • Confirm the timeline for the registration statement effectiveness to ensure compliance with the 45-day requirement.
  • Assess the dilution impact of the 19.99% Exchange Cap and the potential issuance of Penalty Shares if deadlines are missed.
  • Review the Company's liquidity position post-transaction, considering the $4.5 million cash inflow against the $11.6 million principal obligation due in nine months.
  • Monitor for any "Subsequent Financing" that could trigger Most Favored Nation rights or further dilution.